Homocysteine and Early Diastolic Dysfunction in Newly Diagnosed Hypertension
Recruiting
Observational Study
Hypertension (HTN)
Hyperhomocysteinemia
Diastolic Dysfunction
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 500 (estimated)
- Sponsor
- Necmettin Erbakan University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This prospective single-center observational study aims to evaluate the relationship between elevated plasma homocysteine levels and early echocardiographic abnormalities in patients with newly diagnosed essential hypertension. Adult patients diagnosed with essential hypertension within the previous 6 months will undergo clinical assessment, ambulatory blood pressure monitoring, electrocardiograph…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults aged 18 years or older
* Newly diagnosed essential hypertension within the previous 6 months
* Ability and willingness to provide informed consent
* Availability for clinical evaluation, laboratory testing, ambulatory blood pressure monitoring, electrocardiography, and …
Contacts